array(40) {
  [0]=>
  string(4) "2591"
  ["article_id"]=>
  string(4) "2591"
  [1]=>
  string(86) "Hepatitis cases linked to turmeric supplements rises to four, say Italian authorities "
  ["article_title"]=>
  string(86) "Hepatitis cases linked to turmeric supplements rises to four, say Italian authorities "
  [2]=>
  string(152) "Italyâs National Institute of Health has received further notifications of two more hepatitis cases linked to a turmeric-based food supplement distri"
  ["short_description"]=>
  string(152) "Italyâs National Institute of Health has received further notifications of two more hepatitis cases linked to a turmeric-based food supplement distri"
  [3]=>
  string(231) "Italyâs National Institute of Health has received further notifications of two more hepatitis cases linked to a turmeric-based food supplement distributed by a firm already implicated in two similar incidents earlier this month."
  ["description"]=>
  string(231) "Italyâs National Institute of Health has received further notifications of two more hepatitis cases linked to a turmeric-based food supplement distributed by a firm already implicated in two similar incidents earlier this month."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "35"
  ["rss_id"]=>
  string(2) "35"
  [14]=>
  string(188) "https://www.nutraingredients.com/Article/2019/05/17/Hepatitis-cases-linked-to-turmeric-supplements-rises-to-four-say-Italian-authorities?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(188) "https://www.nutraingredients.com/Article/2019/05/17/Hepatitis-cases-linked-to-turmeric-supplements-rises-to-four-say-Italian-authorities?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-05-17 13:00:00"
  ["add_date"]=>
  string(19) "2019-05-17 13:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:24:08"
  ["create_at"]=>
  string(19) "2019-05-23 14:24:08"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2506"
  ["article_id"]=>
  string(4) "2506"
  [1]=>
  string(73) "CMS Backs Off Negotiated Price Rules for Part D, Medicare Advantage Drugs"
  ["article_title"]=>
  string(73) "CMS Backs Off Negotiated Price Rules for Part D, Medicare Advantage Drugs"
  [2]=>
  string(153) "&#nl        The Centers for Medicare and Medicaid Services has backed off a proposed rule that would have used the lowest possible payment to a pharmacy "
  ["short_description"]=>
  string(153) "&#nl        The Centers for Medicare and Medicaid Services has backed off a proposed rule that would have used the lowest possible payment to a pharmacy "
  [3]=>
  string(198) "&#nl        The Centers for Medicare and Medicaid Services has backed off a proposed rule that would have used the lowest possible payment to a pharmacy as the baseline price for Medicare.&#nl      "
  ["description"]=>
  string(198) "&#nl        The Centers for Medicare and Medicaid Services has backed off a proposed rule that would have used the lowest possible payment to a pharmacy as the baseline price for Medicare.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(112) "https://www.fdanews.com/articles/191332-cms-backs-off-negotiated-price-rules-for-part-d-medicare-advantage-drugs"
  ["blog_url"]=>
  string(112) "https://www.fdanews.com/articles/191332-cms-backs-off-negotiated-price-rules-for-part-d-medicare-advantage-drugs"
  [15]=>
  string(19) "2019-05-17 05:57:45"
  ["add_date"]=>
  string(19) "2019-05-17 05:57:45"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:18:36"
  ["create_at"]=>
  string(19) "2019-05-23 14:18:36"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2507"
  ["article_id"]=>
  string(4) "2507"
  [1]=>
  string(39) "Gilead CEO Takes Turn on House Hot Seat"
  ["article_title"]=>
  string(39) "Gilead CEO Takes Turn on House Hot Seat"
  [2]=>
  string(163) "&#nl        Gilead CEO Daniel O’Day on Thursday defended his company’s handling of its blockbuster HIV prevention pill Truvada before hostile House D"
  ["short_description"]=>
  string(163) "&#nl        Gilead CEO Daniel O’Day on Thursday defended his company’s handling of its blockbuster HIV prevention pill Truvada before hostile House D"
  [3]=>
  string(182) "&#nl        Gilead CEO Daniel O’Day on Thursday defended his company’s handling of its blockbuster HIV prevention pill Truvada before hostile House Democrats.&#nl      "
  ["description"]=>
  string(182) "&#nl        Gilead CEO Daniel O’Day on Thursday defended his company’s handling of its blockbuster HIV prevention pill Truvada before hostile House Democrats.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(79) "https://www.fdanews.com/articles/191331-gilead-ceo-takes-turn-on-house-hot-seat"
  ["blog_url"]=>
  string(79) "https://www.fdanews.com/articles/191331-gilead-ceo-takes-turn-on-house-hot-seat"
  [15]=>
  string(19) "2019-05-17 05:57:02"
  ["add_date"]=>
  string(19) "2019-05-17 05:57:02"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:18:36"
  ["create_at"]=>
  string(19) "2019-05-23 14:18:36"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2609"
  ["article_id"]=>
  string(4) "2609"
  [1]=>
  string(68) "ASCO Abstracts: Breast Cancer, Precision Treatments in the Spotlight"
  ["article_title"]=>
  string(68) "ASCO Abstracts: Breast Cancer, Precision Treatments in the Spotlight"
  [2]=>
  string(155) "The world’s biggest annual cancer conference is just around the corner. Data presented at the American Society of Clinical Oncology meeting each yea"
  ["short_description"]=>
  string(155) "The world’s biggest annual cancer conference is just around the corner. Data presented at the American Society of Clinical Oncology meeting each yea"
  [3]=>
  string(380) "The world’s biggest annual cancer conference is just around the corner. Data presented at the American Society of Clinical Oncology meeting each year can change medical practice and make or break companies whose drugs are under the microscope. That’s what makes even the “abstracts,” or snippets of data revealed a few weeks before the meeting, […]"
  ["description"]=>
  string(380) "The world’s biggest annual cancer conference is just around the corner. Data presented at the American Society of Clinical Oncology meeting each year can change medical practice and make or break companies whose drugs are under the microscope. That’s what makes even the “abstracts,” or snippets of data revealed a few weeks before the meeting, […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(107) "https://xconomy.com/national/2019/05/16/asco-abstracts-breast-cancer-precision-treatments-in-the-spotlight/"
  ["blog_url"]=>
  string(107) "https://xconomy.com/national/2019/05/16/asco-abstracts-breast-cancer-precision-treatments-in-the-spotlight/"
  [15]=>
  string(19) "2019-05-17 02:09:43"
  ["add_date"]=>
  string(19) "2019-05-17 02:09:43"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:24:09"
  ["create_at"]=>
  string(19) "2019-05-23 14:24:09"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2539"
  ["article_id"]=>
  string(4) "2539"
  [1]=>
  string(62) "EssilorLuxottica: EssilorLuxottica 2019 Annual General Meeting"
  ["article_title"]=>
  string(62) "EssilorLuxottica: EssilorLuxottica 2019 Annual General Meeting"
  [2]=>
  string(45) "EssilorLuxottica 2019 Annual General Meeting "
  ["short_description"]=>
  string(45) "EssilorLuxottica 2019 Annual General Meeting "
  [3]=>
  string(92) "
EssilorLuxottica 2019 Annual General Meeting 
"
  ["description"]=>
  string(92) "
EssilorLuxottica 2019 Annual General Meeting 
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "27"
  ["rss_id"]=>
  string(2) "27"
  [14]=>
  string(132) "http://www.globenewswire.com/news-release/2019/05/16/1826484/0/en/EssilorLuxottica-EssilorLuxottica-2019-Annual-General-Meeting.html"
  ["blog_url"]=>
  string(132) "http://www.globenewswire.com/news-release/2019/05/16/1826484/0/en/EssilorLuxottica-EssilorLuxottica-2019-Annual-General-Meeting.html"
  [15]=>
  string(19) "2019-05-17 01:59:00"
  ["add_date"]=>
  string(19) "2019-05-17 01:59:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:23:54"
  ["create_at"]=>
  string(19) "2019-05-23 14:23:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2610"
  ["article_id"]=>
  string(4) "2610"
  [1]=>
  string(78) "BioClarity, Maker of “Clean, Green” Skincare Products, Raises $13M"
  ["article_title"]=>
  string(78) "BioClarity, Maker of “Clean, Green” Skincare Products, Raises $13M"
  [2]=>
  string(150) "BioClarity, which sells plant-based skincare products to online shoppers, announced Wednesday that it has raised a $13 million investment round. The S"
  ["short_description"]=>
  string(150) "BioClarity, which sells plant-based skincare products to online shoppers, announced Wednesday that it has raised a $13 million investment round. The S"
  [3]=>
  string(393) "BioClarity, which sells plant-based skincare products to online shoppers, announced Wednesday that it has raised a $13 million investment round. The San Diego-based company is part of Adigica Health, an e-commerce company founded in 2016 to develop and market direct-to-consumer healthcare products. Prolog Ventures led the round with a $6 million investment; BioClarity said earlier […]"
  ["description"]=>
  string(393) "BioClarity, which sells plant-based skincare products to online shoppers, announced Wednesday that it has raised a $13 million investment round. The San Diego-based company is part of Adigica Health, an e-commerce company founded in 2016 to develop and market direct-to-consumer healthcare products. Prolog Ventures led the round with a $6 million investment; BioClarity said earlier […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(102) "https://xconomy.com/san-diego/2019/05/16/bioclarity-maker-of-clean-green-skincare-products-raises-13m/"
  ["blog_url"]=>
  string(102) "https://xconomy.com/san-diego/2019/05/16/bioclarity-maker-of-clean-green-skincare-products-raises-13m/"
  [15]=>
  string(19) "2019-05-17 01:25:50"
  ["add_date"]=>
  string(19) "2019-05-17 01:25:50"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:24:09"
  ["create_at"]=>
  string(19) "2019-05-23 14:24:09"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2611"
  ["article_id"]=>
  string(4) "2611"
  [1]=>
  string(65) "ViaCyte, Fate & More: Xconomy Awards San Diego Big Idea Finalists"
  ["article_title"]=>
  string(65) "ViaCyte, Fate & More: Xconomy Awards San Diego Big Idea Finalists"
  [2]=>
  string(150) "The finalists in the Big Idea category of the Xconomy Awards San Diego are pursuing ambitious goals in pursuit of better ways of improving health. The"
  ["short_description"]=>
  string(150) "The finalists in the Big Idea category of the Xconomy Awards San Diego are pursuing ambitious goals in pursuit of better ways of improving health. The"
  [3]=>
  string(325) "The finalists in the Big Idea category of the Xconomy Awards San Diego are pursuing ambitious goals in pursuit of better ways of improving health. Their approaches range, from a new way to deliver insulin to patients with Type 1 diabetes to an innovative method to detect brain trauma that could reduce the need for […]"
  ["description"]=>
  string(325) "The finalists in the Big Idea category of the Xconomy Awards San Diego are pursuing ambitious goals in pursuit of better ways of improving health. Their approaches range, from a new way to deliver insulin to patients with Type 1 diabetes to an innovative method to detect brain trauma that could reduce the need for […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(103) "https://xconomy.com/san-diego/2019/05/16/viacyte-fate-more-xconomy-awards-san-diego-big-idea-finalists/"
  ["blog_url"]=>
  string(103) "https://xconomy.com/san-diego/2019/05/16/viacyte-fate-more-xconomy-awards-san-diego-big-idea-finalists/"
  [15]=>
  string(19) "2019-05-16 23:00:43"
  ["add_date"]=>
  string(19) "2019-05-16 23:00:43"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:24:09"
  ["create_at"]=>
  string(19) "2019-05-23 14:24:09"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2527"
  ["article_id"]=>
  string(4) "2527"
  [1]=>
  string(71) "REACH Air Medical Services Adding Guardian Flight to Company Operations"
  ["article_title"]=>
  string(71) "REACH Air Medical Services Adding Guardian Flight to Company Operations"
  [2]=>
  string(150) "Integration Will Result in Increased Service and Enhanced Care for Patients & Communities Integration Will Result in Increased Service and Enhanced Ca"
  ["short_description"]=>
  string(150) "Integration Will Result in Increased Service and Enhanced Care for Patients & Communities Integration Will Result in Increased Service and Enhanced Ca"
  [3]=>
  string(190) "Integration Will Result in Increased Service and Enhanced Care for Patients & Communities 
Integration Will Result in Increased Service and Enhanced Care for Patients & Communities
"
  ["description"]=>
  string(190) "Integration Will Result in Increased Service and Enhanced Care for Patients & Communities 
Integration Will Result in Increased Service and Enhanced Care for Patients & Communities
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(142) "http://www.globenewswire.com/news-release/2019/05/16/1826361/0/en/REACH-Air-Medical-Services-Adding-Guardian-Flight-to-Company-Operations.html"
  ["blog_url"]=>
  string(142) "http://www.globenewswire.com/news-release/2019/05/16/1826361/0/en/REACH-Air-Medical-Services-Adding-Guardian-Flight-to-Company-Operations.html"
  [15]=>
  string(19) "2019-05-16 23:00:00"
  ["add_date"]=>
  string(19) "2019-05-16 23:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:23:48"
  ["create_at"]=>
  string(19) "2019-05-23 14:23:48"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2658"
  ["article_id"]=>
  string(4) "2658"
  [1]=>
  string(104) "should I give feedback to people who haven’t asked for it during a collaborative writing project?"
  ["article_title"]=>
  string(104) "should I give feedback to people who haven’t asked for it during a collaborative writing project?"
  [2]=>
  string(150) "It’s the Thursday “ask the readers” question. A reader writes: I’m not fully sure that this fits within the scope of AAM ̵"
  ["short_description"]=>
  string(150) "It’s the Thursday “ask the readers” question. A reader writes: I’m not fully sure that this fits within the scope of AAM ̵"
  [3]=>
  string(1772) "
It’s the Thursday “ask the readers” question. A reader writes: I’m not fully sure that this fits within the scope of AAM — it’s not work-related, but I feel that there is a great deal of overlap. I am the head administrator in an online writing group, where members frequently come together to collaborate on […]
&#nl
&#nl
You may also like:
&#nl
&#nl
my boss wants me to collaborate with my coworker more — but his work is bad
&#nl
my staff collaborates so much that I can’t evaluate their work individually
&#nl
my writing partner is a hot mess, coworker hassles me about working from home, and more
&#nl
&#nl
&#nl
&#nl
should I give feedback to people who haven’t asked for it during a collaborative writing project? was originally published by Alison Green on Ask a Manager.
&#nl"
  ["description"]=>
  string(1772) "
It’s the Thursday “ask the readers” question. A reader writes: I’m not fully sure that this fits within the scope of AAM — it’s not work-related, but I feel that there is a great deal of overlap. I am the head administrator in an online writing group, where members frequently come together to collaborate on […]
&#nl
&#nl
You may also like:
&#nl
&#nl
my boss wants me to collaborate with my coworker more — but his work is bad
&#nl
my staff collaborates so much that I can’t evaluate their work individually
&#nl
my writing partner is a hot mess, coworker hassles me about working from home, and more
&#nl
&#nl
&#nl
&#nl
should I give feedback to people who haven’t asked for it during a collaborative writing project? was originally published by Alison Green on Ask a Manager.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "5"
  ["category"]=>
  string(1) "5"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "50"
  ["rss_id"]=>
  string(2) "50"
  [14]=>
  string(136) "https://www.askamanager.org/2019/05/should-i-give-feedback-to-people-who-havent-asked-for-it-during-a-collaborative-writing-project.html"
  ["blog_url"]=>
  string(136) "https://www.askamanager.org/2019/05/should-i-give-feedback-to-people-who-havent-asked-for-it-during-a-collaborative-writing-project.html"
  [15]=>
  string(19) "2019-05-16 22:59:07"
  ["add_date"]=>
  string(19) "2019-05-16 22:59:07"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:24:24"
  ["create_at"]=>
  string(19) "2019-05-23 14:24:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2797"
  ["article_id"]=>
  string(4) "2797"
  [1]=>
  string(39) "Roche suffers third delay on Spark deal"
  ["article_title"]=>
  string(39) "Roche suffers third delay on Spark deal"
  [2]=>
  string(152) "Rocheâs acquisition of Spark was announced at the start of the year but closing the deal has proved difficult after a third delay incurred to give th"
  ["short_description"]=>
  string(152) "Rocheâs acquisition of Spark was announced at the start of the year but closing the deal has proved difficult after a third delay incurred to give th"
  [3]=>
  string(176) "Rocheâs acquisition of Spark was announced at the start of the year but closing the deal has proved difficult after a third delay incurred to give the FTC extra review time."
  ["description"]=>
  string(176) "Rocheâs acquisition of Spark was announced at the start of the year but closing the deal has proved difficult after a third delay incurred to give the FTC extra review time."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(147) "https://www.biopharma-reporter.com/Article/2019/05/16/Roche-Spark-deal-delayed-for-a-third-time?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(147) "https://www.biopharma-reporter.com/Article/2019/05/16/Roche-Spark-deal-delayed-for-a-third-time?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-05-16 22:44:00"
  ["add_date"]=>
  string(19) "2019-05-16 22:44:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:25:13"
  ["create_at"]=>
  string(19) "2019-05-23 14:25:13"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2612"
  ["article_id"]=>
  string(4) "2612"
  [1]=>
  string(68) "Pulmatrix CEO Robert Clarke Steps Down, Ted Raad Appointed Successor"
  ["article_title"]=>
  string(68) "Pulmatrix CEO Robert Clarke Steps Down, Ted Raad Appointed Successor"
  [2]=>
  string(150) "Robert Clarke, the chief executive who led Pulmatrix to the public markets via a reverse merger in 2015, has stepped down from the company and its boa"
  ["short_description"]=>
  string(150) "Robert Clarke, the chief executive who led Pulmatrix to the public markets via a reverse merger in 2015, has stepped down from the company and its boa"
  [3]=>
  string(338) "Robert Clarke, the chief executive who led Pulmatrix to the public markets via a reverse merger in 2015, has stepped down from the company and its board of directors. The Lexington, MA-based company gave no reason for the departure of Clarke, who was promoted from chief scientific officer to CEO in 2012. But Pulmatrix (NASDAQ: […]"
  ["description"]=>
  string(338) "Robert Clarke, the chief executive who led Pulmatrix to the public markets via a reverse merger in 2015, has stepped down from the company and its board of directors. The Lexington, MA-based company gave no reason for the departure of Clarke, who was promoted from chief scientific officer to CEO in 2012. But Pulmatrix (NASDAQ: […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(106) "https://xconomy.com/boston/2019/05/16/pulmatrix-ceo-robert-clarke-steps-down-ted-raad-appointed-successor/"
  ["blog_url"]=>
  string(106) "https://xconomy.com/boston/2019/05/16/pulmatrix-ceo-robert-clarke-steps-down-ted-raad-appointed-successor/"
  [15]=>
  string(19) "2019-05-16 22:35:02"
  ["add_date"]=>
  string(19) "2019-05-16 22:35:02"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:24:09"
  ["create_at"]=>
  string(19) "2019-05-23 14:24:09"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2791"
  ["article_id"]=>
  string(4) "2791"
  [1]=>
  string(62) "BIO 2019 Innovation Zone Company Snapshot: Trellis Biosciences"
  ["article_title"]=>
  string(62) "BIO 2019 Innovation Zone Company Snapshot: Trellis Biosciences"
  [2]=>
  string(79) "The next big medical breakthrough is on the horizon and all it takes is one ..."
  ["short_description"]=>
  string(79) "The next big medical breakthrough is on the horizon and all it takes is one ..."
  [3]=>
  string(874) "The next big medical breakthrough is on the horizon and all it takes is one ..."
  ["description"]=>
  string(874) "The next big medical breakthrough is on the horizon and all it takes is one ..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "102"
  ["rss_id"]=>
  string(3) "102"
  [14]=>
  string(118) "http://feedproxy.google.com/~r/BiotechNow/~3/agztDAR9B0A/bio-2019-innovation-zone-company-snapshot-trellis-biosciences"
  ["blog_url"]=>
  string(118) "http://feedproxy.google.com/~r/BiotechNow/~3/agztDAR9B0A/bio-2019-innovation-zone-company-snapshot-trellis-biosciences"
  [15]=>
  string(19) "2019-05-16 22:00:31"
  ["add_date"]=>
  string(19) "2019-05-16 22:00:31"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:25:10"
  ["create_at"]=>
  string(19) "2019-05-23 14:25:10"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}